Literature DB >> 10567906

Over-expression and lack of retinoblastoma protein are associated with tumor progression and metastasis in hepatocellular carcinoma.

A M Hui1, X Li, M Makuuchi, T Takayama, K Kubota.   

Abstract

To determine the role of retinoblastoma (Rb) gene alteration in hepatocarcinogenesis, we examined Rb protein expression immuno-histochemically in a series of surgically resected specimens including non-cancerous liver tissues with cirrhosis or chronic hepatitis, large regenerative nodules, pre-cancerous adenomatous hyperplasias as well as primary and metastatic lesions of hepatocellular carcinoma (HCC). All of the non-cancerous liver tissues, large regenerative nodules and adenomatous hyperplasias showed normal Rb protein expression. Altered Rb protein expression was observed in 31 (lack of Rb protein in 16 and over-expression in 15) of the 81 primary HCCs (38%) and was significantly associated with tumor differentiation grade: altered Rb protein expression occurred in 1 of 23 (4%), 16 of 43 (37%) and 14 of 15 (93%) well-, moderately and poorly differentiated tumors (moderately vs. well-differentiated p < 0.01; poorly vs. moderately differentiated p < 0.001). Incidences of both Rb protein absence and over-expression were higher for moderately differentiated than for well-differentiated tumors and even higher for poorly differentiated tumors. Rb protein absence and over-expression were observed in 9 (39%) and 10 (44%) of the 23 metastatic lesions of HCC, respectively, and the incidence of altered Rb protein expression (absence or over-expression) was significantly higher than in primary lesions (83% vs. 38%, p < 0.001). Our observations suggest that elevated and absent Rb protein are closely associated with tumor progression and developing metastatic disease rather than tumor initiation in cases of HCC. Int. J. Cancer (Pred. Oncol.) 84:604-608, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567906     DOI: 10.1002/(sici)1097-0215(19991222)84:6<604::aid-ijc11>3.0.co;2-y

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  RB Loss Promotes Prostate Cancer Metastasis.

Authors:  Chellappagounder Thangavel; Ettickan Boopathi; Yi Liu; Alex Haber; Adam Ertel; Anshul Bhardwaj; Sankar Addya; Noelle Williams; Stephen J Ciment; Paolo Cotzia; Jeffry L Dean; Adam Snook; Chris McNair; Matt Price; James R Hernandez; Shuang G Zhao; Ruth Birbe; James B McCarthy; Eva A Turley; Kenneth J Pienta; Felix Y Feng; Adam P Dicker; Karen E Knudsen; Robert B Den
Journal:  Cancer Res       Date:  2016-12-06       Impact factor: 12.701

3.  Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma.

Authors:  Kai Liu; Xue-Zhong Lei; Lian-San Zhao; Hong Tang; Li Liu; Ping Feng; Bing-Jun Lei
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

4.  Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma.

Authors:  H Iida; M Honda; H F Kawai; T Yamashita; Y Shirota; B-C Wang; H Miao; S Kaneko
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 5.  CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

Authors:  Ming-Chung Jiang
Journal:  Tumour Biol       Date:  2016-09-05

6.  Expression of altered retinoblastoma protein inversely correlates with tumor invasion in gastric carcinoma.

Authors:  Nan-Hua Chou; Hui-Chun Chen; Nan-Song Chou; Ping-I Hsu; Hui-Hwa Tseng
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

7.  Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues.

Authors:  Geertu Deli; Can-Hao Jin; Rong Mu; Song Yang; Yue Liang; De Chen; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

8.  Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.

Authors:  Y Z Shi; A M Hui; T Takayama; X Li; X Cui; M Makuuchi
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

9.  MicroRNA‑153‑3p suppresses retinoblastoma cell growth and invasion via targeting the IGF1R/Raf/MEK and IGF1R/PI3K/AKT signaling pathways.

Authors:  Long Guo; Yu Bai; Tianyu Ni; Yuan Li; Rong Cao; Shuzhe Ji; Shuzhen Li
Journal:  Int J Oncol       Date:  2021-05-26       Impact factor: 5.650

10.  Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.

Authors:  W Wang; L-Y Yang; G-W Huang; W-Q Lu; Z-L Yang; J-Q Yang; H-L Liu
Journal:  Br J Cancer       Date:  2004-06-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.